Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)
HKD 9.47
(1.5%)
HKD 9.47
(1.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 340.64 Million CNY | -10.2% |
| 2022 | 366.96 Million CNY | -11.04% |
| 2021 | 360.99 Million CNY | 21.18% |
| 2020 | 349.78 Million CNY | 14.52% |
| 2019 | 295.57 Million CNY | 141.35% |
| 2018 | 124.19 Million CNY | 37.25% |
| 2017 | 87.51 Million CNY | 11.42% |
| 2016 | 79.29 Million CNY | 91.63% |
| 2015 | 44.39 Million CNY | -9.08% |
| 2014 | 48.02 Million CNY | 12.3% |
| 2013 | 42.06 Million CNY | 9.56% |
| 2012 | 39.22 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 13.97 Million CNY | -77.37% |
| 2024 Q1 | 61.76 Million CNY | -36.89% |
| 2023 Q3 | 54.26 Million CNY | -21.18% |
| 2023 Q1 | 63.15 Million CNY | -51.86% |
| 2023 Q2 | 68.85 Million CNY | 9.03% |
| 2023 Q4 | 97.86 Million CNY | 80.34% |
| 2023 FY | - CNY | -10.2% |
| 2022 Q4 | 131.17 Million CNY | 322.79% |
| 2022 Q3 | 31.02 Million CNY | -62.89% |
| 2022 Q2 | 83.61 Million CNY | -1.97% |
| 2022 FY | - CNY | -11.04% |
| 2022 Q1 | 85.29 Million CNY | -29.65% |
| 2021 Q2 | 102.24 Million CNY | 24.05% |
| 2021 FY | - CNY | 21.18% |
| 2021 Q3 | 54.05 Million CNY | -47.13% |
| 2021 Q4 | 121.23 Million CNY | 124.3% |
| 2021 Q1 | 82.42 Million CNY | -13.88% |
| 2020 Q2 | 101.38 Million CNY | 145.27% |
| 2020 FY | - CNY | 14.52% |
| 2020 Q4 | 95.71 Million CNY | 0.0% |
| 2020 Q3 | 95.71 Million CNY | -5.6% |
| 2020 Q1 | 41.33 Million CNY | -46.48% |
| 2019 Q2 | 62.42 Million CNY | -0.0% |
| 2019 FY | - CNY | 141.35% |
| 2019 Q4 | 77.23 Million CNY | 0.0% |
| 2019 Q3 | 77.23 Million CNY | 23.73% |
| 2019 Q1 | 62.42 Million CNY | 91.06% |
| 2018 Q4 | 32.67 Million CNY | 0.0% |
| 2018 FY | - CNY | 37.25% |
| 2018 Q3 | 32.67 Million CNY | 17.02% |
| 2018 Q2 | 27.91 Million CNY | -0.0% |
| 2018 Q1 | 27.91 Million CNY | 39.81% |
| 2017 Q2 | 20.7 Million CNY | -0.0% |
| 2017 FY | - CNY | 11.42% |
| 2017 Q1 | 20.7 Million CNY | 40.56% |
| 2017 Q4 | 19.96 Million CNY | 0.0% |
| 2017 Q3 | 19.96 Million CNY | -3.54% |
| 2016 FY | - CNY | 91.63% |
| 2016 Q1 | 20.76 Million CNY | 210.78% |
| 2016 Q4 | 14.72 Million CNY | 0.0% |
| 2016 Q2 | 20.76 Million CNY | -0.0% |
| 2016 Q3 | 14.72 Million CNY | -29.07% |
| 2015 Q2 | 14.92 Million CNY | 0.0% |
| 2015 Q3 | 6.68 Million CNY | -55.24% |
| 2015 Q1 | 14.92 Million CNY | -14.56% |
| 2015 Q4 | 6.68 Million CNY | 0.0% |
| 2015 FY | - CNY | -9.08% |
| 2014 FY | - CNY | 12.3% |
| 2014 Q3 | 11.76 Million CNY | -2.91% |
| 2014 Q2 | 12.11 Million CNY | -0.0% |
| 2014 Q1 | 12.11 Million CNY | -31.88% |
| 2014 Q4 | 17.47 Million CNY | 48.57% |
| 2013 Q1 | 10.52 Million CNY | 0.0% |
| 2013 Q2 | 10.52 Million CNY | 0.0% |
| 2013 Q3 | 10.52 Million CNY | 0.0% |
| 2013 Q4 | 17.78 Million CNY | 68.91% |
| 2013 FY | - CNY | 9.56% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | 10.52 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 104.43 Million HKD | -226.19% |